Structural Optimization of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II by Modification of the P1 Side Chain

doi 10.1021/jm051019l.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Interactions Between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization†

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2008English

Promoter Analysis of Human Glutamate Carboxypeptidase II

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2007English

Structural Basis of Interactions Between Human Glutamate Carboxypeptidase II and Its Substrate Analogs

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
2008English

Modification of the Cysteamine Side Chain of Thienamycin. I.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1986English

Chemical Transformation of Gilvocarcin v Modification of the Side-Chain.

Journal of Antibiotics
Drug DiscoveryPharmacology
1993English

Phenotypic Characterization of Mice Heterozygous for a Null Mutation of Glutamate Carboxypeptidase II

Synapse
Molecular NeuroscienceCellular
2009English

Catabolism of the Cholesterol Side Chain in Mycobacterium Tuberculosis Is Controlled by a Redox-Sensitive Thiol Switch

ACS Infectious Diseases
Infectious Diseases
2017English

Hydrophobic Side Chain Dynamics of a Glutamate Receptor Ligand Binding Domain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Thiol Modification by Pharmacologically Active Agents of the Diazeniumdiolate Class

Forum on Immunopathological Diseases and Therapeutics
BiochemistryBiotechnologyGeneticsMolecular Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy